Cancer treatments, despite their transformative potential, often come with unintended cardiovascular risks. Cardio-oncology focuses on understanding and mitigating these risks through a combination of cutting-edge diagnostics and personalized care. By using technologies like cardiac MRI and strain imaging, clinicians can detect early signs of heart stress caused by therapies such as radiation or targeted treatments. This collaborative field not only emphasizes prevention but also explores innovative therapeutics to repair heart damage. As survival rates improve, the integration of cardio-oncology ensures long-term health, enabling patients to overcome cancer without compromising cardiovascular wellness.
Title : Revolutionizing CKD care: How finerenone transforms outcomes in heart and kidney health - Insights from fidelio-DKD
Robert J Chilton, University of Texas Health Science Center San Antonio, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options for pulmonary hypertension and right heart failure
Yong Xiao Wang, Albany Medical Center, United States
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : The problem of sepsis in acute inflammation of lung tissue
Igor Klepikov, Tel Aviv University, Russian Federation
Title : TED2HOME - A low cost automatic external defibrillator for home/office
Abraham Teddy Weiss, Hadassah University Hospital, Israel
Title : Subclinical atherosclerosis: Association with additional risk factors and somatic diseases
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation